->

Ukwelashwa okusha kwesixazululo somdlavuza wepancreatic kuyaphuma

Yabelana ngalokhu okuthunyelwe

Engxoxweni ebisanda kwenziwa, uDkt Afsaneh Barzi, ongumsizi kaprofesa wezokwelapha emtholampilo e-University of Southern California Norris Comprehensive Cancer Center, ukunitshele ngezindlela zokwelapha ezintsha ze-adjuvant ezikhona neziqhamukayo zeziguli ezinomdlavuza ongahlonzi we-pancreatic.

IGemcitabine inikezwa iziguli ezinomdlavuza we-pancreatic njengomkhuba ojwayelekile wokuhlola impendulo. Kodwa-ke, uBarzi uthe impendulo yesiguli ku-gemcitabine ibimbi kakhulu futhi iziguli eziningi azikwazi ukuhlinzwa. Isivivinyo se-LAPACT siphenye ukwelashwa okuhlanganisiwe kwe-gemcitabine ne-nab-paclitaxel (Abraxane). Ukuhlolwa kukhombisa ukuthi iziguli ezingama-36% zomdlavuza wepancreatic ziyasabela ekwelashweni, kanti cishe iziguli ezingama-15% zomdlavuza wepancreatic zingathola ukwelashwa okuhlinzwa.

Ngaphezu kwalokho, ukuhlaziywa kwe-meta yocwaningo lwe-FOLFIRINOX lweziguli ezinomdlavuza we-pancreatic osezingeni eliphezulu kubonise ukuthi cishe ama-28% eziguli ezinomdlavuza we-pancreatic akwazi ukuhlinzwa. U-Barzi wachaza ukuthi njengoba i-chemotherapy isebenza kakhulu, amathuba okukhishwa kabusha ayanda. Ngakho-ke, ukukhishwa kabusha kwesiguli kufanele kuhlolwe ngokufanele. U-Barzi uphethe ngokuthi nakuba iziguli eziningi zingase zingakufanelekeli ukuhlinzwa, kusafanele ukuhlola iziguli ukuze kutholwe iziguli ezingahlinzwa ngemva kokwelashwa kwe-neoadjuvant.

https://www.onclive.com/conference-coverage/soss-gi-usc-2018/dr-barzi-on-available-and-emerging-neoadjuvant-approaches-in-pancreatic-cancer

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Alysha Mendossa April 29, 2024
Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell
Ukwelashwa kwe-CAR T-Cell

Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell

Abezimo eziphuthumayo badlala indima ebalulekile empumelelweni yokwelashwa kwe-CAR T-cell ngokuqinisekisa ukunakekelwa kwesiguli okungenamthungo kuyo yonke inqubo yokwelashwa. Banikeza ukwesekwa okubalulekile ngesikhathi sokuthutha, ukuqapha izimpawu ezibalulekile zeziguli, nokuphatha ukungenelela kwezokwelapha eziphuthumayo uma izinkinga ziphakama. Ukusabela kwabo okusheshayo kanye nokunakekelwa kochwepheshe kunomthelela ekuphepheni okuphelele nasekusebenzeni ngempumelelo kokwelashwa, kusiza uguquko olushelelayo phakathi kwezilungiselelo zokunakekelwa kwezempilo kanye nokwenza ngcono imiphumela yesiguli endaweni eyinselele yezindlela zokwelapha ezithuthukisiwe zamaselula.

Susan Hau April 29, 2024

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Xhumana nathi
Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton